Foley's Catheter Balloon for Induction of Mid Trimester Abortion in Nulliparous Women With or Without Tension Applied
1 other identifier
interventional
200
1 country
1
Brief Summary
Induction of abortion is a hot subject that has complex and emotional controversy. The most common time of abortion is the second trimester which represent about 10-15% of all induced abortions over the world. As well as, two-thirds of all serious abortion-related complications are related to induced second trimester abortion. There are many causes for induction of abortion in the second trimester such as missed abortion, serious fetal abnormalities such as central nervous system or skeletal malformation and lastly some women do not wish to continue a pregnancy and will often seek out termination of pregnancy. Termination of second trimester is more risky than the first trimester. So many lines have been emerged to achieve safe and effective method of termination of second trimester. Pharmacologic management seems to be an appealing method for induction of abortion. The combing between mifepristone and misoprostol is the effective regimen for termination of second trimester abortion with success rate reaching about 97-99% within 24 hours. However, mifepristone is not available or affordable in many countries worldwide so misoprostol have been used alone but it needs higher total dose with lower effectiveness and higher percentage of side effects rate than the combined regimens. The optimal method for inducing second trimester nulliparous women with an unfavorable cervix is not known. Several studies in literature have described the effectiveness of Foley's catheter in cervical ripening and improvement of Bishop's score in women with unripe cervices . It may act in addition to its mechanical effect by increasing the release of prostaglandin and/or oxytocin release secondary to localized inflammation. In practice, the insertion of intra-cervical Foley's catheter balloon is followed by applying tension in trial to shorten the time between the insertion and expulsion of the fetus, however; this tension adds more pain for the pregnant women with higher rate of vaginal bleeding and dissatisfaction. Gary et al in 2016 concluded that the application of tension did not result in faster delivery times, but did result in faster times to catheter expulsion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 15, 2016
CompletedFirst Posted
Study publicly available on registry
July 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedMarch 2, 2018
February 1, 2018
1.1 years
July 15, 2016
February 28, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
The degree of pain provoked by catheter measured by visual analogue scale
6 hours
Secondary Outcomes (1)
The time from insertion of Foley catheter balloon to catheter expulsion.
12 hours
Study Arms (2)
Foley Catheter Balloon with Tension group
OTHERa 16 French transcervical Foley catheter balloon will be advanced to or past the internal os and the balloon will be filled. Then catheter will be placed on gentle traction by taping the distal tip to the medial thigh for maximum 24 hours. To maintain gentle traction, periodic repositioning of the distal tip on the thigh will be necessary.
Foley Catheter Balloon without tension group
OTHERThe Foley catheter balloon will be just supported by simple taping to the thigh.
Interventions
Eligibility Criteria
You may qualify if:
- Singleton second trimester (12-28 weeks) pregnancy.
- Nulliparous woman.
- Bishop score ≤ 6.
- BMI 18-22.5 kg/m2
You may not qualify if:
- Multiple gestations.
- Premature rupture of membranes before induction.
- Pregnancy complicated by antepartum hemorrhage (placenta previa or abruptio placenta).
- Low amniotic fluid volume (\< 5cm).
- Scarred uterus including hysterotomy or myomectomy.
- Uterine infection.
- Unexplained bleeding.
- Latex allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Women Health Hospital - Assiut university
Asyut, 71111, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
July 15, 2016
First Posted
July 22, 2016
Study Start
July 1, 2016
Primary Completion
August 1, 2017
Study Completion
September 1, 2017
Last Updated
March 2, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will share